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Influenza A virus (IAV) assembly and budding on host cell surface plasma membrane 
requires actin cytoskeleton reorganization. The underlying molecular mechanism 
involving actin reorganization remains unclarified. In this study, we found that the 
natural antiviral compound petagalloyl glucose (PGG) inhibits F-actin reorganization 
in the host cell membrane during the late stage of IAV infection, which are associated 
with the suppression of total cofilin-1 level and its phosphorylation. Knock-down of 
cofilin-1 reduces viral yields. These findings provide the first evidence that cofilin-1 




 Influenza A virus (IAV) infection enhances F-actin aggregation on plasma 
membrane. 
 Pentagalloyl glucose (PGG) inhibits F-actin aggregation and viral nucleoprotein 
accumulation on plasma membrane which was associated with suppressions of total 
cofilin-1 and its phosphorylation.  
 Knock-down of cofilin-1 reduces IAV yields from host cells. 
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1. Introduction 
Influenza A virus (IAV) remains a global health concern because of the emergence of 
novel virus subtypes or strains potentially capable of causing pandemics [1,2,3]. Due 
to high mutation rate during IAV replication, emergence of antiviral drug resistance is 
a major concern in influenza antiviral treatment [4], and highlights the need for new 
drug development. To avoid antiviral drug resistance, more attention is paid to find 
new targets for antiviral therapy that targeting host cell factors. This strategy requires 
understanding of molecular and cellular mechanisms involved in IAV infection and 
replication.  
Host actin cytoskeleton has been reported to be involved in various stages of the 
IAV life cycle [5,6]. Actin filament depolymerization with CytoD and stabilization 
with jasplakinolide both inhibited influenza entry, suggesting that dynamic actin 
cytoskeletal reorganization is required for successful internalization of IAV into cells 
[5]. Actin cytoskeleton is also responsible for intracellular trafficking of IAV after 
entry, since treatment of cells with CytoD restricted intracellular viral movement [7]. 
Actin is associated with maintaining the lipid raft, where the assembly of IAV takes 
place, for incorporation into the budding filamentous virions [6]. Actin cytoskeleton 
interacts with several viral proteins (NP, M1 and M2) and provides the pushing force 
for incorporating the cytoplasmic vRNP complex into the budding site on plasma 
membrane [8,9,10,11]. A recent study revealed that influenza viral membrane protein 
HA clusters co-localize with actin-rich membrane regions and actin disruption caused 
specific changes to HA clustering [12]. Additionally, actin and actin-associated 
proteins are found in influenza virus particles [13]. These suggested that actin 
cytoskeleton also plays a critical role in the process of influenza virus assembly and 
budding.  
Regulation of actin cytoskeleton requires several actin binding proteins, which 
organize the actin filaments (F-actin) into higher order structures such as actin 
bundles, branches, filopodia and microvilli [14]. The actin-depolymerizing factor 
(ADF)/cofilin family and gelsolin were previously reported to be essential regulators 
of actin cytoskeleton dynamics [15,16]. ADF/cofilin family consists of three highly 
similar paralogs: ADF (destrin), cofilin-1(non-muscle tissue) and cofilin-2 (muscle 
cofilin) [17]. ADF/cofilin family proteins accelerate the dissociation rate of actin 
subunits and server F-actin, which are primarily responsible for actin cytoskeleton 
remodeling [18]. The mammalian cofilin-1 is the most ubiquitous and involved in 
viral infection. HIV-1 inactivates cofilin to optimize immune evasion, replication, 
release, and cell-cell transmission [19,20,21]. We have previously reported that 
cofilin-1 play a crucial role in mediating biphasic F-actin dynamics to facilitate HSV-
1 infection and replication [22,23]. Cofilin-1 mediates the inhibition of actin-
cytoskeleton remodeling and the anti-HSV activity of pentagalloyl glucose (PGG) 
[24]. Additionally, we found that PGG also inhibits IAV production by suppressing 
viral NP accumulation and virion budding on plasma membrane, which may be 
relevant to actin cytoskeleton remodeling [25]. Therefore, we speculated that cofilin-1 
may play a role in IAV assembly and budding.  
In this study, we found that IAV-induced F-actin aggregation on plasma membrane 
was possibly associated with total level of cofilin-1 protein and phosporylation, which 
were suppressed by PGG treatment. Moreover, we demonstrated that both cofilin-1 
knock-down and PGG treatment can reduce viral yields. This study provides the first 
evidence that cofilin-1 is involved in regulation of actin reorganization during IAV 
assembly and budding.  
 
2. Materials and methods 
2.1 Cells, virus and reagents 
MDCK and A549 cells were grown in DMEM or MEM (Invitrogen) supplemented 
with 10% FBS (Cell Culture Bioscience) and antibiotics (100U/ml penicillin and 
100μg/ml streptomycin, Nacalai tesque). Influenza virus A/WSN/33 (H1N1) was 
propagated in 10-day-old embryonated chicken eggs. The allantoic fluids were 
harvested at 4 days after inoculation and stored at -80°C. Pentagalloyl glucose (PGG) 
was prepared as described previously [26].  
 
2.2 Laser scanning confocal immunofluorescence microscopy 
MDCK cells were infected with influenza A/WSN/33 (MOI=1) and then treated with 
DMSO or PGG. At 12h p.i., cells were fixed with 4% paraformaldehyde (Wako) and 
permeabilized with 1%Triton X-100 (Nacalai tesque). F-actin was stained with 
TRITC-Phalloidin (50ng/ml, Sigma-Aldrich) for 15 min. Viral NP protein was stained 
by using specific antibody against influenza A NP proteins (Santa Cruz Biotech). For 
deconvolution, a 63× Plan Apo objective was used for image acquisition and images 
were acquired at 0.5-μm steps in the z axis using a laser scanning system, LSM710 
(Carl Zeiss).  
 
2.3 Transmission electron microscopy (TEM) 
MDCK cells were mock-infected or infected with influenza virus 
A/WSN/33(MOI=1). At 12h p.i., cells were fixed in 3% glutaraldehyde (pH 7.2) for 
1.5 hours, and post-fixed in 1% osmium tetroxide for 1 hour. After dehydration, cells 
were embedded in Spurr’s resin. Several consecutive ultrathin sections were cut on an 
LKB Nova ultramicrotome and then stained with saturated uranyl acetate and lead 
citrate. These sections were examined under a transmission electron microscope, 
JEM1400. 
 
2.4 Cofilin-1 siRNA preparation and transfection 
Cofilin-1 was knocked down with a specific targeting siRNA duplex consisting of 
oligo-DNAs with sequences 5’-GUCUUCAACGCCAGAGGAGTT-3’ and 5’-
CUCCUCUGGCGUUGAAGACTT-3’. The scrambled siRNA duplex of oligo-DNAs 
5’-UUCUCCGAACGUGUCACGUTT-3’ and 5’-ACGUGACACGUUCGGAGAA 
TT-3’ that does not target any gene product was used as a negative control. All 
siRNAs were obtained from Shanghai GenePharma Co., Ltd. A549 cells were 
transfected with 100 nM siRNA in reduced serum medium OPTI-MEM-I (Invitrogen) 
according to the manufacturer’s protocol. After 36 hours incubation, the cells were 
infected with influenza A/WSN/33 (MOI=1). Cells and culture supernatants were 
harvested at 12h p.i. for Western blotting or virus titer quantification as previously 
reported [25].  
 
2.5 Western blotting 
Cell lysates were subjected to SDS-PAGE. Proteins were transferred to 
polyvinylidene fluoride (PVDF) membrane for Western blotting analysis, which was 
performed using specific antibodies against influenza A viral M1 proteins (Santa Cruz 
Biotech), β-actin(Sigma-Aldrich), α-tubulin (Sigma-Aldrich), cofilin-1 (Calbiochem) 
or phosphorylated cofilin-1 (Sigma-Aldrich). Bound antibodies were visualized with 
an enhanced chemiluminescence (ECL) Plus Kit (GE Healthcare Life Sciences).  
 
2.6 Statistics analysis 
Statistical analysis was performed with Student’s t-tests. Differences with P values of 
less than 0.05 were considered statistically significant. 
 
3. Results 
3.1 IAV-induced aggregation of F-actin on cell surface membrane was suppressed by 
antiviral agent PGG 
To confirm whether PGG can alter the surface actin filament-based structure, we 
performed a fluorescent TRITC phalloidin-labeled F-actin staining and TEM 
observation of infected cells in the presence or absence of PGG. As shown in Fig. 1A, 
mock-infected cells displayed sparse microvilli on the cell surface membrane, while 
more microvilli with expanded branches were observed in infected cells treated with 
or without DMSO (Fig. 1A upper panel), accompanied with aggregation of F-actin at 
margins of cells (Fig. 1A lower panel). In contrast, the IAV-induced microvilli-like 
protrusions and aggregation of F-actin was markedly inhibited by PGG treatment (Fig. 
1A). The relative F-actin fluorescence intensity was analyzed semi-quantitatively and 
showed that PGG significantly inhibited IAV-induced augment of F-actin (Fig. 1B). 
We also examined the distributions of F-actin and viral NP protein on the surface 
plasma membrane of infected cells in the presence or absence of PGG using confocal 
laser scanning microscopy (Fig.1C). Z-axis reconstructions showed that increased 
accumulations of viral NP protein and co-localization with F-actin were found in the 
DMSO-treated cells, whereas the accumulations and co-localization were 
significantly reduced by PGG treatment (Fig.1D). Together, we concluded that IAV-
induced microvilli-like structures on the surface of plasma membrane were associated 
with F-actin aggregation, which were significantly decreased by PGG treatment.  
 
3.2 PGG did not alter expression level of actin but significantly reduced the 
expression level of cofilin-1 during IAV infection 
We further confirmed the total expression levels of β-actin and cofilin-1 
(regulator of actin cytoskeleton remodeling) in infected cells in the presence or absent 
of PGG by using Western blotting (Fig.2A). No significant changes in the total 
expression level of β-actin were observed either in mock-infected cells or IAV-
infected cells in the presence of DMSO or PGG (in indicated concentrations) (Fig.2 
B). However, the total expression level of cofilin-1 was significantly reduced by PGG 
treatment in a dose-dependent manner (Fig.2C). We calculated the ratio of cofilin-1 to 
actin was and found that the ratio was significantly increased after IAV infection but 
significantly suppressed by PGG treatment in a dose-dependent manner (Fig.2D).  
 
3.3 PGG inhibits IAV-induced cofilin-1expression and phosphorylation 
We further examined the time-course effects of PGG treatment on total 
expression level and phosphorylation of cofilin-1 after IAV infection by using 
Western blotting (Fig.3A). Total cofilin-1 level was increased in IAV-infected cells 
treated with DMSO (Fig.3 B). In contrast, the total cofilin-1 level was time-
dependently reduced by PGG treatment (Fig.3B). Furthermore, IAV infection leads to 
cofilin-1 phosphorylation increase in DMSO-treated cells in a time-dependent manner, 
but the phosphorylated cofilin-1 (p-cofilin-1) level was markedly suppressed in PGG-
treated infected cells (Fig.3C).  
 
3.4 Cofilin-1 is involved in IAV production 
To confirm whether cofilin-1 plays a role in IAV production, we examined the 
viral titer in culture supernatants from infected cells, which were treated by DMSO or 
PGG with different concentrations for 12h. As shown in Fig.4A, PGG dose-
dependently reduced virus yield. To further confirm the involvement of cofilin-1 in 
IAV production, we knocked down the endogenous cofilin-1 by siRNA, then infected 
the cells with influenza A/WSN/33 (MOI=1). As shown in Fig.4B, cofilin-1 siRNA 
significantly reduced their target mRNA level. Virus titer from the cofilin-knocked 
down cells was significantly reduced (Fig.4C), suggesting that cofilin is involved in 
virus production. 
 
4. Discussion  
 
Actin microfilaments (also called F-actin) are critical for the maturation step of 
many viruses [27,28,29]. Some host actin-binding proteins, such as Rab 11 and 
myosin, are essential for IAV genome transport to the plasma membrane and budding 
formation [30,31,32,33]. The major actin-depolymerizing factor (ADF)/cofilin 
isoform, Cofilin-1 is primarily responsible for dynamic actin cytoskeletal 
reorganization [15], and functions depending on its local concentration of active form 
relative to actin: relative low concentrations of active cofilin to actin favor severing, 
whereas high concentrations of cofilin favor nucleating actin assembly [34]. Cofilin-1 
is deactivated by phosphorylation on Ser-3 by LIM-kinase1 (LIMK1), and results in 
an increase in F-actin [35, 36]. Disruption of the LIMK1-cofilin pathway affected 
viral releases of Mason-Pfizer monkey virus (M-PMV) and HIV-1 [21], as well as the 
entry and replication of HSV-1 [22,23,24]. However, there are no reports on IAV. In 
this study, we found that IAV infection enhanced surface cellular F-actin remodeling 
at the late stage of IAV replication cycle which was associated with an increase in the 
total expression and phosphorylation level of cofilin-1. We have previously shown 
that PGG treatment reduces cofilin-1 expression in HSV-infected cells [24], here we 
also found PGG can significantly reduce cofilin-1 expression in IAV-infected cells, 
suggesting cofilin-1 is involved in the antiviral effects of PGG against different 
viruses. The inhibitions of total and phosphorylation level of cofilin-1 by PGG may 
be associated with dynamic remodeling of F-actin in IAV-infected cells, subsequently 
leads to decrease in IAV production, which was also confirmed by cofilin-1 siRNA 
knockdown experiment.  
IAV infection results in activation of phosphoinositide 3-kinase (PI3K) signaling 
pathway, which may inactivates cofilin and promote F-actin polymerization [23, 37, 
38]. It has been reported that PGG reduces the expression of PI3K as well as 
phosphorylation of AKT and mammalian target of rapamycin (mTOR) [39]. It is 
likely that PGG suppress IAV-induced cofilin-1 phosphorylation via inhibition of the 
PI3K/Akt pathway.  
In conclusion, our findings reveal that cofilin-1 plays an important role in 
mediating anti-IAV effects of PGG on viral assembly and budding during the late 
stage of IAV replication cycle. Understanding the underlying mechanism by which 
IAV regulates cofilin-1 activity to remodeling actin cytoskeleton may provide 
valuable insights into assembly and budding of IAV, leading to discovery of novel 
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Fig.1 IAV-induced aggregation of F-actin on cell surface was suppressed by 
antiviral agent PGG. (A) MDCK cells were mock-infected or infected with 
influenza A/WSN/33 (MOI=1) in the presence or absence of PGG (12.5μg/ml) or 
DMSO (0.1%, v/v). At 12h p.i., cells were examined with a transmission electron 
microscopy (scale bar = 1 μm). After stainning with Phalloidin-TRITC, the pattern of 
F-actin in cells was imaged using a confocal laser scanning microscopy. (B) Semi-
quantification of F-actin accumulated on plasma membrane in infected cells in the 
presence or absence of PGG. (C) F-actin (stained with Phalloidin-TRITC in red) and 
viral NP protein (stained with anti-viral NP antibodies in green) was imaged by 
confocal laser scanning microscopy. Representative z-plane reconstructions (xz-axis) 
are shown (Scale bar = 20µm). Areas of colocalization are evidenced in yellow. (D) 
Semi-quantification of viral NP protein accumulated on plasma membrane in infected 
cells in the presence or absence of PGG. Each value represents the mean and SD of 
three separate experiments (*P<0.05). 
 
Fig.2 PGG did not alter expression level of actin but significantly reduced 
expression level of cofilin-1 during IAV infection. (A) A549 cells were infected 
with A/WSN/33 (MOI=1) and subsequently treated with PGG (indicated 
concentration) or DMSO (0.1%, v/v). At 12h p.i., cells were analyzed by Western 
blotting analysis to determine the expressions of viral M1, cofilin-1, β-actin and α-
tubulin proteins. (B, C) The relative expression levels of β-actin and cofilin-1 
normalizing to that of α-tubulin. (D) The ratio of total cofilin-1 to β-actin was 
calculated and represented. Each value represents the mean and SD of three separate 
experiments (*P<0.05).  
 
Fig.3 PGG inhibits IAV-induced cofilin-1 expression and phosphorylation. (A) 
A549 cells were infected with A/WSN/33 (MOI=1) and subsequently treated with 
PGG (12.5μg/ml) or DMSO (0.1%, v/v). At 0, 3, 6, 9, 12 and 24 h p.i., cells were 
lysed and subjected to Western blotting to determine the expression of viral M1, 
cofilin-1, phorsphorylated cofilin-1 and α-tubulin proteins. Relative expression level 
of cofilin-1 (B) and phosphorylated cofilin-1 (C) was calculated by normalizing to 
that of α-tubulin, respectively. Each value represents the mean and SD of three 
separate experiments (*P<0.05). 
 
Fig.4 Cofilin-1 is involved in influenza virus production. (A) A549 cells were 
infected with A/WSN/33 (MOI=1) and subsequently treated with PGG (indicated 
concentrations) or DMSO (0.1%, v/v). At 12 h p.i., culture supernatant was harvested 
and the virus titer was determined by plaque assay. (B) A549 cells were transfected 
with siRNAs for 36h, and then infected with influenza A/WSN/33(MOI=1) for 12h 
p.i.. Expression of cofilin-1 was determined by Western blotting. si.NC and si.cofilin 
present scrambled siRNA and cofilin-1 siRNA respectively. (C) Viral titers from 
different culture supernatants were determined by plaque assay. Each value represents 
the mean and SD of three separate experiments (*P<0.05). 
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